134 related articles for article (PubMed ID: 22672290)
1. A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting.
Bowling FL; Abbott CA; Harris WE; Atanasov S; Malik RA; Boulton AJ
Diabet Med; 2012 Dec; 29(12):1550-2. PubMed ID: 22672290
[TBL] [Abstract][Full Text] [Related]
2. The Ipswich Touch Test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration.
Sharma S; Kerry C; Atkins H; Rayman G
Diabet Med; 2014 Sep; 31(9):1100-3. PubMed ID: 24673517
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes.
Bracewell N; Game F; Jeffcoate W; Scammell BE
Diabet Med; 2012 Dec; 29(12):1553-5. PubMed ID: 22672257
[TBL] [Abstract][Full Text] [Related]
4. The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration.
Rayman G; Vas PR; Baker N; Taylor CG; Gooday C; Alder AI; Donohoe M
Diabetes Care; 2011 Jul; 34(7):1517-8. PubMed ID: 21593300
[TBL] [Abstract][Full Text] [Related]
5. The utility of Vibratip in accurate identification of loss of protective sensation in the contralateral foot of patients admitted with a diabetic foot ulcer.
Pasangha E; George B; Jayalakshmi V; Devi P; Ayyar V; Bantwal G
Diabetes Metab Syndr; 2021; 15(3):857-862. PubMed ID: 33873055
[TBL] [Abstract][Full Text] [Related]
6. Utilizing the Ipswich Touch Test to simplify screening methods for identifying the risk of foot ulceration among diabetics: The Saudi experience.
Madanat A; Sheshah E; Badawy el-B; Abbas A; Al-Bakheet A
Prim Care Diabetes; 2015 Aug; 9(4):304-6. PubMed ID: 25466160
[TBL] [Abstract][Full Text] [Related]
7. Screening for the loss of protective sensation in people without a history of diabetic foot ulceration: Validation of two simple tests in India.
Chatzistergos PE; Kumar S; Sumathi CS; Mahadevan S; Vas P; Chockalingam N
Diabetes Res Clin Pract; 2023 Aug; 202():110810. PubMed ID: 37391033
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
Kamei N; Yamane K; Nakanishi S; Yamashita Y; Tamura T; Ohshita K; Watanabe H; Fujikawa R; Okubo M; Kohno N
J Diabetes Complications; 2005; 19(1):47-53. PubMed ID: 15642490
[TBL] [Abstract][Full Text] [Related]
9. Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy.
Valabhji J; Marshall RC; Lyons S; Bloomfield L; Hogg D; Rosenfeld P; Gabriel CM
Diabet Med; 2012 Sep; 29(9):1191-4. PubMed ID: 22276944
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different screening tests for detecting diabetic foot neuropathy.
Forouzandeh F; Aziz Ahari A; Abolhasani F; Larijani B
Acta Neurol Scand; 2005 Dec; 112(6):409-13. PubMed ID: 16281925
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of SET--a new device for the measurement of pain perception in comparison to standard measures of diabetic neuropathy.
Nguyen M; Henniges W; Lobisch M; Reifert S; Larbig M; Pfützner A; Forst T
Diabetes Technol Ther; 2004 Oct; 6(5):601-6. PubMed ID: 15628814
[TBL] [Abstract][Full Text] [Related]
12. Hidden dangers revealed by misdiagnosed diabetic neuropathy: A comparison of simple clinical tests for the screening of vibration perception threshold at primary care level.
Azzopardi K; Gatt A; Chockalingam N; Formosa C
Prim Care Diabetes; 2018 Apr; 12(2):111-115. PubMed ID: 29029862
[TBL] [Abstract][Full Text] [Related]
13. Vibration perception threshold: are multiple sites of testing superior to single site testing on diabetic foot examination?
Armstrong DG; Hussain SK; Middleton J; Peters EJ; Wunderlich RP; Lavery LA
Ostomy Wound Manage; 1998 May; 44(5):70-4, 76. PubMed ID: 9697548
[TBL] [Abstract][Full Text] [Related]
14. An alternative to a 10-g monofilament or tuning fork? Two new, simple, easy-to-use screening tests for determining foot ulcer risk in people with diabetes.
Baker N
Diabet Med; 2012 Dec; 29(12):1477-9. PubMed ID: 22686252
[No Abstract] [Full Text] [Related]
15. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
Oguejiofor OC; Odenigbo CU; Oguejiofor CB
Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
[TBL] [Abstract][Full Text] [Related]
16. Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication.
Gin H; Rigalleau V; Baillet L; Rabemanantsoa C
Diabetes Metab; 2002 Dec; 28(6 Pt 1):457-61. PubMed ID: 12522325
[TBL] [Abstract][Full Text] [Related]
17. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Clinical Tests for Peripheral Diabetic Neuropathy in a Type 1 Diabetes Cohort.
César Ernesto LC; Néstor MZ; Raúl IS; Francisco Javier PV; Tania S MU; Francisco BH; Alejandro CM; Marcela JZ; Almeda-Valdes P
Endocr Pract; 2021 Jun; 27(6):567-570. PubMed ID: 33798738
[TBL] [Abstract][Full Text] [Related]
19. A review of the current evidence on the sensitivity and specificity of the Ipswich touch test for the screening of loss of protective sensation in patients with diabetes mellitus.
Hu A; Koh B; Teo MR
Diabetol Int; 2021 Apr; 12(2):145-150. PubMed ID: 33786269
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.
Kamenov ZA; Petrova JJ; Christov VG
Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):226-33. PubMed ID: 20200815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
